We are live on ! Find out more
CNFG

Creegan & Nassoura Financial Group Portfolio holdings

AUM $154M
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
-6.14%
1 Year Est. Return
+17.18%
3 Year Est. Return
+52.61%
5 Year Est. Return
+77.6%
10 Year Est. Return
AUM
$115M
AUM Growth
-$3.59M
Cap. Flow
+$5.11M
Cap. Flow %
4.43%
Top 10 Hldgs %
30.88%
Holding
77
New
4
Increased
16
Reduced
19
Closed
1

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.51M
2
HON icon
Honeywell
HON
+$1.08M
3
BX icon
Blackstone
BX
+$992K
4
AVGO icon
Broadcom
AVGO
+$903K
5
NKE icon
Nike
NKE
+$557K

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$187K
2
UL icon
Unilever
UL
+$124K
3
SYK icon
Stryker
SYK
+$105K
4
VZ icon
Verizon
VZ
+$102K
5
PLTR icon
Palantir
PLTR
+$95K

Sector Composition

Rank Sector Weight
1 Healthcare 17.98%
2 Industrials 17.37%
3 Financials 16.17%
4 Consumer Staples 12.8%
5 Technology 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$4.55M 3.95%
19,553
+524
+3% +$138K
BX icon
2
Blackstone
BX
$102B
$4.21M 3.65%
50,255
+10,240
+26% +$992K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.85M 3.34%
14,421
CI icon
4
Cigna
CI
$73.7B
$3.76M 3.26%
13,551
-50
-0.4% -$14.1K
JPM icon
5
JPMorgan Chase
JPM
$935B
$3.62M 3.14%
34,639
+1,095
+3% +$126K
PG icon
6
Procter & Gamble
PG
$336B
$3.4M 2.95%
26,913
DEO icon
7
Diageo
DEO
$49B
$3.33M 2.89%
19,628
MRK icon
8
Merck
MRK
$322B
$3.11M 2.7%
36,138
+58
+0.2% +$5.18K
GIS icon
9
General Mills
GIS
$19.1B
$3.02M 2.62%
39,390
-400
-1% -$30.5K
JNJ icon
10
Johnson & Johnson
JNJ
$618B
$2.77M 2.4%
16,942
-25
-0.1% -$4.23K
AAPL icon
11
Apple
AAPL
$4.54T
$2.74M 2.38%
19,843
+48
+0.2% +$7.53K
UNP icon
12
Union Pacific
UNP
$174B
$2.72M 2.36%
13,963
ETN icon
13
Eaton
ETN
$161B
$2.67M 2.31%
20,019
SCHA icon
14
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$2.55M 2.21%
134,758
+182
+0.1% +$3.81K
DE icon
15
Deere & Co
DE
$160B
$2.52M 2.19%
7,557
WPC icon
16
W.P. Carey
WPC
$16.8B
$2.4M 2.08%
35,087
DIS icon
17
Walt Disney
DIS
$167B
$2.36M 2.05%
25,056
+775
+3% +$82.9K
CVS icon
18
CVS Health
CVS
$133B
$2.32M 2.01%
24,317
EPD icon
19
Enterprise Products Partners
EPD
$82.3B
$2.18M 1.89%
91,680
ITW icon
20
Illinois Tool Works
ITW
$82.6B
$2.13M 1.85%
11,805
+17
+0.1% +$3.35K
UNH icon
21
UnitedHealth
UNH
$376B
$2.09M 1.81%
4,135
ENB icon
22
Enbridge
ENB
$119B
$2.06M 1.79%
55,625
PFF icon
23
iShares Preferred and Income Securities ETF
PFF
$13.3B
$2.03M 1.76%
64,000
PEP icon
24
PepsiCo
PEP
$190B
$1.99M 1.73%
12,215
+2
+0% +$345
XOM icon
25
ExxonMobil
XOM
$644B
$1.98M 1.71%
22,659

Similar funds

Creegan & Nassoura Financial Group's Q3 2022 Portfolio in Review

As of Q3 2022, Creegan & Nassoura Financial Group held 77 positions worth $115M, down 3% from $119M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Creegan & Nassoura Financial Group deployed $5.11M of net new capital in Q3 2022, opening 4 new positions and adding to 16 existing holdings. Its largest new stake was Medtronic: 16,849 shares worth $1.36M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was US Bancorp, an estimated $187K trimmed.

  • Creegan & Nassoura Financial Group's largest Q3 2022 buy was Medtronic: 16,849 shares worth $1.36M.
  • Creegan & Nassoura Financial Group added most to Blackstone in Q3 2022, an estimated $992K increase.
  • Creegan & Nassoura Financial Group's biggest Q3 2022 reduction was US Bancorp, cutting an estimated $187K.
  • Creegan & Nassoura Financial Group fully exited Palantir in Q3 2022, selling an estimated $95K.
  • Creegan & Nassoura Financial Group's ten largest holdings make up 31% of its $115M portfolio in Q3 2022.
  • Creegan & Nassoura Financial Group opened 4 new positions and closed 1 in Q3 2022.
  • Creegan & Nassoura Financial Group's portfolio value fell 3% quarter-over-quarter to $115M.

Based on Creegan & Nassoura Financial Group's 13F filing for Q3 2022, filed 14 Nov 2022.